For Flexible Facilities
For Single-Use Applications
New Programming Updates

Email Opt-In

Download Brochure

Social Networking


Join our LinkedIn Group: BioProcessing Professionals.


Add BDP Week to your Facebook calendar by clicking "Join" on the event page


Follow @IBCBioProcess on Twitter for special offers and news about the event.


View our YouTube channel

IBC Social Media Contact: Jenny Pereira

Add to Outlook Calendar

BioProcess International

Get up-to-date with the global industrial biotherapeutic community from BioProcess International™ Magazine


  • Recommend to a Friend
  • LinkedIn
  • YouTube
  • Blog
  • IBC Feed
  • FiercePharma Manufacturing Feed

Keynote Presentations

Keynote Presentations

Session Highlights

  • Keynote or Featured Presentation
  • Case Study
  • New Data
  • Panel Discussion

Keynote Presentations

Monday, March 30, 2015

Registration and Coffee

Chairperson's Opening Remarks
Günter Jagschies, Ph.D., Senior Director, Strategic Customer Relations, Biotechnologies R&D, GE Healthcare Life Sciences, Sweden

Presentation TBA

Dana Andersen, Ph.D. Challenges and Opportunities in Pharmaceutical Development
Increasing needs to improve the efficiency of development together with new opportunities such as Breakthrough Therapy designation, will require novel approaches and innovations to be successful. Specific examples and opportunities will be discussed focusing on drug product development but many of which are more broadly applicable as well.
Dana C. Andersen, Ph.D., Senior Director, Pharmaceutical Development, U.S. Biologics Technical Development, Genentech - a Member of the Roche Group

Networking Refreshment Break in Poster and Exhibit Hall

Wednesday, April 1, 2015

Registration and Coffee

Chairperson's Remarks
Uwe Gottschalk, Ph.D., Chief Technology Officer, Pharma Biotech, Lonza, Switzerland

Tae Han Kim Manufacturing in a Global Market Place
As the CEO of leading contract manufacturing organization - Samsung BioLogics, Dr. TH Kim presents the implication of manufacturing segment in the whole business value chain of biopharmaceutical industry. Beginning with the trend forecast of growing demand and supply of manufacturing capacity, he talks about the limitation of in-house manufacturing and a solution to manufacturing optimization in global market place.
Tae Han Kim, Ph.D., President and CEO, Samsung BioLogics

Hitto Kaufmann, Ph.D. Innovation in Biologics Manufacturing
Hitto Kaufmann, Ph.D., Vice President, Technology and Innovation, Sanofi Biologics, Germany

Networking Refreshment Break in Poster and Exhibit Hall

BPI 2015
Charles River

Google Adwords